Search

You searched for "pharmaceuticals"

176 results found

Streamlining cataract lists: how are you managing it?

1 October 2021 | | EYE - Cataract, EYE - Refractive, EYE - General
Mr Jonathan Ross, in conversation with Ms Bita Manzouri, provides a personal perspective on challenges and opportunities shaping the future of cataract surgery services across the hospital eye service. Redesigning cataract pathways in response to COVID-19 Bita Manzouri: Over the...

The College of Optometrists welcomes seven new Life Fellows, two new Honorary Fellows and a Fellow by Portfolio

20 November 2024 | awards, achievements, events, meetings, diary, optometry, optometrist, royal college
The College awarded new Fellowships at the annual Diploma Ceremonies in Westminster in November 2024. The College of Optometrists has recognised the outstanding achievements and contributions of 10 individuals working in eye health by awarding new Life and Honorary Fellowships...

What's trending Jun/Jul 2023

5 June 2023 | | EYE - General
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #whoopigoldberg #presbyopia #bionic Whoopi Goldberg made a name for herself in blockbusters such as the Oscar-winning Ghost and Sister Act. She...

My Top Five: Promising gene therapies for ocular conditions

4 December 2024 | | EYE - Vitreo-Retinal
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...

My Top Five: Promising gene therapies for ocular conditions

4 December 2024 | | EYE - Vitreo-Retinal
Gene therapy, a pivotal advancement in modern medicine, particularly shines in ophthalmology. By targeting defective genes with engineered vectors, this approach promises significant strides in treating inherited retinal diseases. This article reviews the top five gene therapies in late-stage trials,...
Eye journal cover image.

Current and emerging strategies for myopia control

3 February 2026 | | EYE - Refractive
This is a review of the current literature and strategies for myopia control. It discusses the epidemiology of myopia, the classification of myopia and the current treatment strategies. It presents data from landmark papers while discussing treatment strategies which they...

Update on emerging therapies for age-related macular degeneration

4 December 2023 | | EYE - Vitreo-Retinal
The 23rd European Society of Retina Specialists (EURETINA) Congress, held in Amsterdam, the Netherlands, provided a timely update on anti-complement therapy for geographic atrophy and emerging investigational therapies for neovascular age-related macular degeneration. Anti-complement therapy for geographic atrophy Geographic atrophy...

Learnings and trends in the management of open-angle and angle-closure glaucoma

1 August 2017 | | EYE - Glaucoma
To be truly disruptive, newer technologies need to offer a quality of life benefit over medication to a broad population of glaucoma sufferers. Evidence and converging trends in medical and surgical management of glaucoma were explored in counterpoint discussions and...

Are we short-sighted about myopia?

1 December 2017 | | EYE - Cataract, EYE - Refractive, EYE - General
Worldwide prevalence of myopia has increased rapidly in recent years and has now reached epidemic levels, particularly in South-East Asia where prevalence is around 80% [1-4]. Myopia prevalence is also increasing in the United States and Europe where it is...

Recurrent corneal erosions secondary to isotretinoin use

7 December 2020 | | EYE - Cornea, EYE - Glaucoma
Isotretinoin (13–cis-retinoic acid) is the first line treatment for moderate to severe nodulocystic or papulopustular acne [1,2]. Although it is a safe medication, it has several adverse side-effects, including ophthalmic manifestations, as shown in Table 1 [3]. These side-effects need...

Demodex blepharitis: A transatlantic comparison of treatments available in the UK and US

1 April 2026 | | EYE - Cornea, EYE - Oculoplastic
Demodex blepharitis is widely recognised among eyecare professionals as an important cause of chronic lid margin inflammation, dry eye and ocular surface diseases. The characteristic feature for diagnosis is the presence of waxy deposit at the lash bases on slit...

The role of inflammation in the pathophysiology of DMO

1 February 2016 | | EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is a major cause of visual loss in diabetes, with a complex multifactorial pathogenesis. In the UK alone it is estimated that there are nearly 2.5 million diabetic patients aged over 12 years. Approximately 65,000 of...